Streamlined Facial Rejuvenation: A Randomized Split-Face Trial of Premixed Intradermal Botulinum Toxin Type A and Hyaluronic Acid Biorevitalization
Premixed intradermal BoNT-A with NCTF 135HA achieved superior wrinkle reduction, enhanced skin quality, and greater patient satisfaction than BoNT-A alone, with minimal downtime and an excellent safety profile.
Authors
- Islam Alzayadneh (ORCID: https://orcid.org/0009-0006-6514-4744)
- Nisreen Al-Musaileem
- Aseel Doubi (ORCID: https://orcid.org/0000-0002-5209-4278)
- Richard Rival
- Lana Alzayadneh
- Philip Solomon (ORCID: https://orcid.org/0000-0001-8880-1205)
- Omar Hamdan (ORCID: https://orcid.org/0009-0008-0442-0578)
- Leen Alhuneafat
- Saleh Abualhaj (ORCID: https://orcid.org/0009-0004-3243-9007)
- Abdalrhman Albassomi
Institutions
- University of Toronto (CA)
- Mutah University (JO)
- Jordan Hospital (JO)
- King Saud Medical City (SA)
- Al-Balqa Applied University (JO)
- Ministry of Health (KW)
Publication Details
- Journal
- Aesthetic Surgery Journal
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1093/asj/sjaf213
- Citations
- 1
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.00